Vaneck Biotech Etf Analysis

BBH Etf  USD 153.01  0.90  0.58%   
VanEck Biotech ETF is fairly valued with Real Value of 154.92 and Hype Value of 152.73. The main objective of VanEck Biotech etf analysis is to determine its intrinsic value, which is an estimate of what VanEck Biotech ETF is worth, separate from its market price. There are two main types of VanEck Etf analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic stability of VanEck Biotech ETF. On the other hand, technical analysis, focuses on the price and volume data of VanEck Etf to identify patterns and trends that may indicate its future price movements.
The VanEck Biotech etf is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. VanEck Biotech is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. VanEck Etf trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and VanEck Biotech's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

VanEck Etf Analysis Notes

VanEck Biotech is is formed as Regulated Investment Company in the United States. ETF is managed and operated by Van Eck Associates Corporation. The fund has 26 constituents with avarage daily trading value of 8.6 K. The fund charges 0.35 percent management fee with a total expences of 0.35 percent of total asset. The fund holds 99.96% of assets under management (AUM) in equities. VanEck Biotech ETF last dividend was 0.472 per share. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States. For more info on VanEck Biotech ETF please contact the company at NA.

Sector Exposure

VanEck Biotech ETF constituents include assets from different sectors. As a result, investing in VanEck Biotech lets you gain exposure to equities across multiple sectors, sub-sectors, or industries. This can reduce the risk of holding a single asset or a fund not diversified across different sectors or industries. Typically, investors would invest in VanEck Biotech because they prefer to avoid the increased volatility of non-sector ETFs.
Different industry classifications and sub-sectors that are found among VanEck Biotech's constituents divide the investing landscape into groups of entities that employ similar trades or provide related services. Combining these segments enables in-depth research of market dynamics to see which parts of the economy are growing or fading. In addition, sector investments offer targeted exposure to these segments, giving investors a wide variety of options to enhance their portfolios' asset allocations and adapt to market volatility.

VanEck Biotech ETF Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more etfs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. VanEck Biotech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding VanEck Biotech ETF or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
VanEck Biotech ETF generated a negative expected return over the last 90 days
Latest headline from zacks.com: Should You Invest in the VanEck Biotech ETF
The fund generated three year return of -6.0%
VanEck Biotech ETF holds 99.96% of its assets under management (AUM) in equities

VanEck Biotech Thematic Classifications

In addition to having VanEck Biotech etf in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Health Care ETFs Idea
Health Care ETFs
USA ETFs from Health Care clasification
Sector ETFs Idea
Sector ETFs
USA ETFs from Sector clasification

Management Efficiency

VanEck Biotech's management efficiency ratios could be used to measure how well VanEck Biotech manages its routine affairs as well as how well it operates its assets and liabilities.
The analysis of VanEck Biotech's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze VanEck Biotech's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of VanEck Etf analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Max Mgmt Charge
0.00
Holdings Turnover
0.18
Holdings Count
25
Net Expense Ratio
0.0035
Total Assets
414.9 M

Top VanEck Biotech ETF Etf Constituents

BGNEBeiGeneStockCancer Fighters
ILMNIlluminaStockMeasuring and Control Equipment
VRTXVertex PharmaceuticalsStockPharmaceutical Products
SGENSeagen IncStockSeagen
REGNRegeneron PharmaceuticalsStockBiotech
NVAXNovavaxStockBiotechnology
MRNAModernaStockBiotechnology
IQVIQVIA HoldingsStockLife Sciences Tools & Services
INCYIncyteStockBiotechnology
GILDGilead SciencesStockMacroaxis Index
GHGuardant HealthStockHealthcare
EXASEXACT SciencesStockBiotechnology
CRLCharles River LaboratoriesStockLife Sciences Tools & Services
BMRNBiomarin PharmaceuticalStockBiotechnology
BIIBBiogen IncStockHedge Favorites
AMGNAmgen IncStockHealth Management

Institutional Etf Holders for VanEck Biotech

Have you ever been surprised when a price of an equity instrument such as VanEck Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading VanEck Biotech ETF backward and forwards among themselves. VanEck Biotech's institutional investor refers to the entity that pools money to purchase VanEck Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Note, although VanEck Biotech's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Technical Drivers

As of the 18th of April 2024, VanEck Biotech has the Risk Adjusted Performance of (0.09), coefficient of variation of (685.42), and Variance of 0.9255. VanEck Biotech technical analysis provides you with a way to harness past market data to determine a pattern that measures the direction of the etf's future prices. In other words, you can use this information to find out if the etf will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have analyzed thirteen technical drivers for VanEck Biotech ETF, which can be compared to its competition. Please validate VanEck Biotech ETF variance, maximum drawdown, as well as the relationship between the Maximum Drawdown and skewness to decide if VanEck Biotech is priced more or less accurately, providing market reflects its prevalent price of 153.01 per share.

VanEck Biotech ETF Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. VanEck Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for VanEck Biotech ETF. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

VanEck Biotech Predictive Daily Indicators

VanEck Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of VanEck Biotech etf daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

VanEck Biotech Forecast Models

VanEck Biotech's time-series forecasting models are one of many VanEck Biotech's etf analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary VanEck Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About VanEck Etf Analysis

Etf analysis is the technique used by a trader or investor to examine and evaluate how VanEck Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VanEck shares will generate the highest return on investment. We also built our etf analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Etf such as VanEck Biotech. By using and applying VanEck Etf analysis, traders can create a robust methodology for identifying VanEck entry and exit points for their positions.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our etf analysis tools, you can find out how much better you can do when adding VanEck Biotech to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Bond Analysis Now

   

Bond Analysis

Evaluate and analyze corporate bonds as a potential investment for your portfolios.
All  Next Launch Module
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.